v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Comprehensive Income [Abstract]    
Revenue $ 7 $ 3
Operating expenses:    
Research and development 43,447 43,174
General and administrative 14,046 13,494
Other operating income, net (119) (1,090)
Total operating expenses 57,374 55,578
Loss from operations (57,367) (55,575)
Interest income, net 3,862 6,819
Other income, net 1,310 1,090
Impairment of other investments 0 (13,001)
Total other income (loss), net 5,172 (5,092)
Net loss (52,195) (60,667)
Other comprehensive loss:    
Net unrealized loss on marketable securities (133) (310)
Comprehensive loss $ (52,328) $ (60,977)
Net loss per common share, basic (in dollars per share) $ (0.18) $ (0.24)
Net loss per common share, diluted (in dollars per share) $ (0.18) $ (0.24)
Weighted-average shares used to compute net loss per common share, basic (in shares) 295,098 254,252
Weighted-average shares used to compute net loss per common share, diluted (in shares) 295,098 254,252